Vaishali Pharma Complete Financial Statements
VAISHALI • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Vaishali Pharma (VAISHALI).
Downloads include all available records across all periods.
For market performance, see the
VAISHALI stock price today
.
Profitability Ratios
Net Profit Margin
2.94%
2025 data
EBITDA Margin
5.88%
2025 data
Operating Margin
4.00%
2025 data
Return on Assets
0.91%
2025 data
Return on Equity
1.54%
2025 data
Balance Sheet Ratios
Current Ratio
21.00
2025 data
Debt to Equity
1.69
2025 data
Equity Ratio
59.09%
2025 data
Asset Turnover
0.31
2025 data
Year-over-Year Growth Analysis
Comparing Jun 2025 vs Sept 2025
Revenue Growth
+36.0%
Year-over-Year
Expense Growth
+45.5%
Year-over-Year
Assets Growth
+37.5%
Year-over-Year
Equity Growth
+51.2%
Year-over-Year
Liabilities Growth
+37.5%
Year-over-Year
Operating Cash Flow Growth
-1900.0%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year
Financing Cash Flow Growth
+2000.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Jun 2025 |
|---|---|---|
| Revenue | 34 | 25 |
| Expenses | 32 | 22 |
| EBITDA | 2 | 2 |
| Operating Profit Margin % | 4.00% | 6.00% |
| Depreciation | 0 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 2 | 2 |
| Tax | 1 | 1 |
| Net Profit | 1 | 1 |
| Earnings Per Share (₹) | 0.09 | 0.10 |
Related Pages for Vaishali Pharma
Additional stock information and data for VAISHALI
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Total Assets | 110 | 80 | 79 | 82 | 86 | 66 | 69 | 64 | 45 |
| Current Assets | 105 | 75 | 73 | 76 | 81 | 61 | 63 | 59 | 40 |
| Fixed Assets | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| Capital Work in Progress | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 107 | 77 | 76 | 80 | 84 | 64 | 67 | 62 | 43 |
| LIABILITIES | |||||||||
| Total Liabilities | 110 | 80 | 79 | 82 | 86 | 66 | 69 | 64 | 45 |
| Current Liabilities | 5 | 4 | 6 | 3 | 4 | 4 | 5 | 3 | 4 |
| Non-Current Liabilities | |||||||||
| SHAREHOLDERS' EQUITY | |||||||||
| Total Equity | 65 | 43 | 41 | 26 | 22 | 21 | 21 | 21 | 4 |
| Share Capital | 26 | 11 | 11 | 11 | 11 | 11 | 7 | 7 | 3 |
| Reserves & Surplus | 39 | 32 | 30 | 16 | 12 | 11 | 15 | 14 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -18 | 1 | 1 | 1 | 2 | 3 | 4 | -10 | 1 | 5 | -4 |
| Investing Activities | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 1 | 3 | 2 |
| Financing Activities | 19 | -1 | -2 | 0 | -2 | -3 | -4 | 9 | -1 | -8 | 2 |
| Net Cash Flow | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |